Kimbra Kenney MD

Education

BA, The Johns Hopkins University, Baltimore, MD, 1980
MD, University of Virginia School of Medicine, Charlottesville, VA, 1984
Internship, Harbour-UCLA, Los Angeles, CA, 1985, Internal Medicine
Residency, Oregon Health Sciences University, Portland, OR, 1988, Neurology
Fellowship, University of Washington, Seattle, WA, 1989, Neuropathology
Clinical Associate, Laboratory of Central Nervous System Studies, NINDS, NIH, 1993-2001, Transmissible spongiform encephalopathies

Biography

Supported the USNH-Naples, Italy from 1990-1992; served as a Clinical Associate in the Laboratory of Central Nervous System Studies (LCNSS), NINDS, NIH under Drs. Carleton Gajdusek and C. J. Gibbs, studying biomarkers and the pathophysiology of human and zoonotic prion disorders from 1993-1997; continued prion disease work as a Medical Officer 200-2002; worked as a clinical researcher in the Comprehensive Neuroscience Program (CNP) in the Department of Neurology, USUHS, under Dr. Bill Campbell 2006-2011 studying militarily relevant neurological disorders with a focus on biomarkers of musculoskeletal disorders ( e.g. exertional rhabdomyolysis), Collaborated with Dr. Ramon Diaz-Arrastia in the Department of Neurology, USUHS, studying military/veteran traumatic brain injury (TBI) 2011-2016; worked at NICoE, WRNMMC continuing clinical research of TBI 2016-2023; supporting TBI studies and grants through the Dept of Neurology, USUHS, 2023-present.

Representative Bibliography

Brown PW, Kenney K, et al., The intracerebral distribution of infectious amyloid protein in patients with spongiform encephalopathy. Annals Neurology 38: 2 (August), 245-253, 1995.

Alperovitch A, Bradley R, Diringer H, Gibbs J, Kenney K, et al. Public health issues and clinical and neurological characteristics of the new variant of Creutzfeldt-Jakob disease and other human and animal transmissible spongiform encephalopathies. Bulletin World Health Org 74 (5):453-463, 1996.

Hsich G, Kenney K, Gibbs CJ, Lee K, et al., The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. The New England J Medicine, 38 (No. 13, September 26): 924-930, 1996.

Will RG, Zeidler M, Brown P, Harrington M, Lee K, Kenney K, Cerebrospinal fluid test for new-variant Creutzfeldt-Jakob disease. Lancet, 348 (October 5): 955, 1996.

Bird T, Kraft G, Lipe, Kenney K, Sumi M, Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: A 20 year study, Annals Neurology 41: 4 (April), 463-369, 1997.

Kenney K, Landau ME, Gonzalez RS, Hundertmark J, O’Brien K, Campbell WW. Serum CK after exercise - drawing the line between physiologic response and exertional rhabdomyolysis? Muscle and Nerve, 2012. Mar;45(3):356–362.

Kenney K, Amyot F, Haber M, Pronger A, Bogoslovsky T, Moore C, Diaz-Arrastia R. Vascular Injury in Traumatic Brain Injury. Exp Neurol. 2016;275(3):353-366.

Amyot F, Kenney K, Moore C, Haber M, Turtzo LC, Shenouda C, Silverman E, Harburg L, Gandhbakjche A, Wassermann E, Diaz-Arrastia R. Imaging of Cerebrovascular Function in Chronic Traumatic Brain Injury. J Neurotrauma 2017 Oct 25. doi: 10.1089/neu.2017.5114. [Epub ahead of print].

Kenney K, Katz DI, Edlow BL, Diaz-Arrastia R, Daneshvar DH, Dams-O’Connor K, Stevens A, Moreau A, Tirrel L, Varjabedian A, Yendiki A, van der Kouwe A, McNab JA, Gordon WA, Fischl B, McKee AC, Perl DP. Dementia after Single Moderate-Severe Traumatic Brain Injury: Coexistence of Multiple Proteinopathies. J Neuropath Exp Neur, 2018;77(1):50-63.

Kenney K, Amyot F, Moore C, Haber M, Moore C, Turtzo LC, Shenouda C, Silverman E, Gong Y, Qu B, Harburg L, Wassermann E, Lu HY, Diaz-Arrastia R. Phosphodiesterase-5 Inhibition Potentiates Cerebrovascular Reactivity in Chronic Traumatic Brain Injury. Ann Clin Trans Neur, in press, 12-28-2017.